Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Bernard A. Fox"'
Autor:
Tyler W. Hulett, Shawn M. Jensen, Phillip A. Wilmarth, Ashok P. Reddy, Carmen Ballesteros-Merino, Michael E. Afentoulis, Christopher Dubay, Larry L. David, Bernard A. Fox
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-14 (2018)
Abstract Background One of today’s greatest hurdles for cancer immunotherapy is the absence of information regarding which tumor antigens are already recognized by patients receiving immunotherapies, and whether those therapies then boost or genera
Externí odkaz:
https://doaj.org/article/705c95563ef14e4eb37c073174ee5387
Publikováno v:
Journal of Human Lactation
Background The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has infected over 127 million people worldwide, with almost 2.8 million deaths at the time of writing. Since no lactating individuals were included in initial trials
ImportanceThe SARS-CoV-2 pandemic has infected over a hundred million people worldwide, with almost 2.5 million deaths at the date of this publication. In the United States, Pfizer-BioNTech and Moderna vaccines were first administered to the public s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad4aee8d2776d0a74500ba6e735d211f
https://doi.org/10.1101/2021.02.23.21252328
https://doi.org/10.1101/2021.02.23.21252328
Autor:
Walter J. Urba, Hong-Ming Hu, Michael E. Afentoulis, Brian D. Piening, Bernard A. Fox, Daniel S. O'Connor, Glenna McDonnell, Jack Lee, Mia Han, Rom Leidner, Keith W. Wegmann, Kim Jaffe, Traci L Hilton, Biance Nguyen, John F. Rodriguez, Christopher Paustian, Madelein Laws, Carlo Bifulco, Shawn M. Jensen, David A. Canton, Tarsem Moudgil, Kellie Malloy Foerter, Christopher G. Twitty
Publikováno v:
Regular and young investigator award abstracts.
Background SARS-CoV-2 (CoV2) has precipitated a global pandemic and the effectiveness of standard vaccine strategies to induce potent and persistent immunity to CoV2 is in question, particularly for the elderly. This problem is not dissimilar to what
Autor:
Cliff Hoyt, John J. McGuire, Ignacio I. Wistuba, Kristin Roman, Carmen Ballesteros-Merino, Edwin R. Parra, Bethany Remeniuk, David L. Rimm, Chichung Wang, Elizabeth L. Engle, Mei Jiang, Shawn M. Jensen, Darren Locke, Carla Coltharp, Bernard A. Fox, Janis M. Taube
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
BackgroundEmerging data suggest predictive biomarkers based on the spatial arrangement of cells or coexpression patterns in tissue sections will play an important role in precision immuno-oncology. Multiplexed immunofluorescence (mIF) is ideally suit
Autor:
Jean S. Campbell, Renata Hermiz, Alain Algazi, Donna Bannavong, Michael Rosenblum, Lawrence Fong, Sharron Gargosky, Erica Browning, Christopher Garris, Scot Ebbinhaus, Christopher G. Twitty, Mikael J. Pittet, Adam B. Olshen, Lauren P. Levine, Robert H.I. Andtbacka, Robert H. Pierce, Bernard A. Fox, Ari Oglesby, Shailender Bhatia, Murray Franco, Sean P. Arlaukas, Katy K. Tsai, Mai Le, Dave Canton, Daud Adlil
Publikováno v:
SSRN Electronic Journal.
Non-response to anti-PD-1 antibodies is characterized by a “cold” tumor microenvironment lacking “exhausted” CD8+ T cells. We report on the first prospective Phase 2 trial of intratumoral plasmid IL-12 and pembrolizumab in advanced melanoma w
Autor:
Bernard A. Fox, Zipei Feng, Michael J. Gough, Rom Leidner, R. Bryan Bell, Marka R. Crittenden
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 73:S107-S115
Autor:
Carmen Ballesteros-Merino, Bernard A. Fox, Phillip A. Wilmarth, Christopher Dubay, Larry L. David, Tyler W. Hulett, Michael E. Afentoulis, Ashok P. Reddy, Shawn M. Jensen
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-14 (2018)
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-14 (2018)
Background One of today’s greatest hurdles for cancer immunotherapy is the absence of information regarding which tumor antigens are already recognized by patients receiving immunotherapies, and whether those therapies then boost or generate an imm
Autor:
Bernard A. Fox, Hong-Ming Hu, Walter J. Urba, Nicholas P. Morris, Andrew D. Weinberg, Zhihua Cui, Li-Xin Wang, Guangjie Yu, Yuhuan Li
Publikováno v:
Scientific Reports
It is well-known that vaccines comprising of irradiated whole tumor cells or tumor-derived heat shock proteins can generate tumor-specific immune responses. In contrast, we showed recently that vaccines composed of autophagosomes (DRibbles) derived f
Autor:
Walter J. Urba, Rachel E. Sanborn, Lana Chisholm, Nicholas P. Morris, Bernard A. Fox, Tarsem Moudgil, Kevin Floyd, Andrew D. Weinberg, Iliana Gonzalez, Joshua M. Walker, Brenda Fisher, Daniel Haley, Eric D. Bernstein, Edwin B. Walker, Nicole Rymarchyk, Tracy L Kelly, Tanisha Meeuwsen, Laurie Delanty-Miller, Todd S. Crocenzi, Magdalena Kovacsovics-Bankowski, Brendan D. Curti, Todd Coffey, William Miller
Publikováno v:
Cancer Research. 73:7189-7198
OX40 is a potent costimulatory receptor that can potentiate T-cell receptor signaling on the surface of T lymphocytes, leading to their activation by a specifically recognized antigen. In particular, OX40 engagement by ligands present on dendritic ce